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Abstract 
Stress-induced reinstatement of cocaine seeking requires corticotropin 
releasing factor (CRF) actions in the ventral tegmental area (VTA). However 
the mechanisms through which CRF regulates VTA function to promote 
cocaine use are not fully understood. Here we examined the role of GABAergic 
neurotransmission in the VTA mediated by GABA-A or GABA-B receptors in 
the reinstatement of extinguished cocaine seeking by a stressor, 
uncontrollable intermittent footshock, or bilateral intra-VTA administration of 
CRF. Rats underwent repeated daily cocaine self-administration 
(1.0 mg/kg/ing; 14 × 6 h/day) and extinction and were tested for 
reinstatement in response to footshock (0.5 mA, 0.5” duration, average every 
40 s; range 10–70 s) or intra-VTA CRF delivery (500 ng/side) following intra-
VTA pretreatment with the GABA-A antagonist, bicuculline, the GABA-B 
antagonist, 2-hydroxysaclofen or vehicle. Intra-VTA bicuculline (1, 10 or 
20 ng/side) failed to block footshock- or CRF-induced cocaine seeking at 
either dose tested. By contrast, 2-hydroxysaclofen (0.2 or 2 μg/side) 
prevented reinstatement by both footshock and intra-VTA CRF at a 
concentration that failed to attenuate food-reinforced lever pressing (45 mg 
sucrose-sweetened pellets; FR4 schedule) in a separate group of rats. These 
data suggest that GABA-B receptor-dependent CRF actions in the VTA 
mediate stress-induced cocaine seeking and that GABA-B receptor 
antagonists may have utility for the management of stress-induced relapse in 
cocaine addicts. 
Keywords: Stress; Relapse; Reinstatement; GABA-B receptors; Ventral 
tegmental area; Cocaine 
1. Introduction 
Understanding the mechanisms that contribute to relapse to 
drug use in cocaine addicts is critical for the development of new and 
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more effective treatment approaches for managing addiction. In rats, 
relapse can be studied using reinstatement models in which the ability 
of a stimulus to re-establish or reinstate cocaine seeking behavior in 
rats or mice following extinction is used as an indicator of its likelihood 
to promote relapse to use in human addicts (Mantsch et al., 2015). 
Many of the same stimuli that contribute to drug use in humans 
(stress, drug-associated cues, drug re-exposure), reinstate cocaine 
seeking following self-administration (SA) and extinction in rats. 
Among the triggers for relapse, stress is particularly problematic 
due to its unpredictable and often uncontrollable nature. Reports from 
cocaine users that relapse is frequently related to the onset of stressful 
life events are supported by laboratory findings demonstrating that 
personalized scripts that relay stress-related imagery can precipitate 
craving in cocaine-dependent individuals (Sinha et al., 1999). In rats, 
it has been reported that a number of stressors can reinstate 
extinguished cocaine seeking following intravenous self-administration 
(see Mantsch et al., 2015 for review). However, most studies 
investigating stress-induced relapse in rats have used electric 
footshock delivered through the grid floor of the operant conditioning 
chambers as the reinstating stressor. Notably, we have previously 
reported that, like stress imagery in human addicts (Fox et al., 2005), 
the ability of footshock to reinstate cocaine seeking in rats increases 
according to the amount of prior drug intake (Mantsch et al., 2008). 
Several studies have demonstrated that stress-induced 
reinstatement of cocaine seeking requires corticotropin-releasing factor 
(CRF) actions in the ventral tegmental area (VTA; Wang et al., 2005, 
Wang et al., 2007, Blacktop et al., 2011, Chen et al., 
2014 and Vranjkovic et al., 2014) and that intra-VTA CRF 
administration is sufficient to reinstate cocaine seeking following SA 
and extinction in rats (Wang et al., 2005 and Blacktop et al., 2011). 
However, the downstream processes in the VTA through which CRF 
promotes drug use are unclear. Mechanistic studies have focused on 
CRF regulation of glutamatergic neurotransmission in the VTA (Wise 
and Morales, 2010). In the VTA, CRF has been reported to increase 
glutamate release as measured by both in vivo microdialysis ( Wang 
et al., 2005) and spontaneous EPSCs in slice preparations ( Hahn 
et al., 2009 and Williams et al., 2014), as well as post-synaptic 
excitability through increases in AMPA:NMDA receptor ratios ( Ungless 
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et al., 2003 and Hahn et al., 2009). Moreover, intra-VTA perfusion 
with kynurenic acid, which has a pharmacological profile that includes 
AMPA and NMDA receptor antagonism, prevents reinstatement in 
response to either footshock or intra-VTA CRF (Wang et al., 2005). 
However, the actions of stress and CRF in the VTA are complex 
and appear to also include, under some circumstances, inhibition of 
neuronal activity (Ungless et al., 2004, Wanat et al., 2013 and Twining 
et al., 2015) or terminal neurotransmitter release (Williams et al., 
2014). The VTA receives dense GABAergic inputs from a number of 
regions, including the nucleus accumbens (Yim and Mogenson, 1980, 
Xia et al., 2011 and Bocklisch et al., 2013) and bed nucleus of the stria 
terminalis (Kudo et al., 2012), both of which have been implicated in 
stress-induced cocaine seeking in rats (Erb and Stewart, 1999, 
McFarland et al., 2004 and Vranjkovic et al., 2014). Additionally, the 
VTA contains GABAergic interneurons that regulate efferent neuronal 
projections from the region (Steffensen et al., 1998 and Cruz et al., 
2004) and dense GABAergic innervation from the rostromedial 
tegmental nucleus (i.e., tail of the VTA; Jhou et al., 2009, Matsui and 
Williams, 2011 and Barrot et al., 2012). It has also been reported that 
CRF promotes GABAergic neurotransmission within the VTA. For 
example, CRF application to the VTA in ex vivo slice preparations 
promotes GABA-B regulation of G protein-coupled inwardly-rectifying 
potassium (GIRK) channels on dopamine cells ( Beckstead et al., 
2009). Despite these findings, the effects of GABA receptor 
antagonism in the VTA on stress-induced reinstatement have not been 
reported. 
In the present study we investigate the potential contribution of 
GABAA and GABAB receptors in the VTA to the reinstatement of 
extinguished cocaine seeking in response to footshock or delivery of 
CRF into the VTA following self-administration. Rats with a history of 
daily self-administration that results in robust shock and intra-VTA 
CRF-induced reinstatement following extinction (14 × 6 h/day; 
1 mg/kg/inf) received intra-VTA injections of the GABAA receptor 
antagonist, bicuculline, or the GABAB receptor antagonist, 2-
hydroxysaclofen, prior to reinstatement testing. Notably, in contrast to 
previous work targeting VTA GABA receptors which used a cocktail of 
receptor agonists (baclofen/muscimol; McFarland et al., 2004), the 
present study uses receptor selective antagonists, thereby permitting 
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1) assessment of the contribution of GABAA vs. GABAB receptors and 
2) the regulation of cocaine seeking through GABAergic signaling that 
is engaged by CRF and/or during stress. 
2. Methods 
2.1. Subjects 
Adult male Sprague–Dawley rats (Harlan Laboratories, St. Louis, 
MO) were housed individually under a 12 h/12 h reversed light/dark 
cycle (lights on at 7:00 PM) in a temperature and humidity controlled 
AAALAC-accredited animal facility. All procedures were approved by 
the Marquette University IACUC and carried out in accordance with the 
NIH Guide for the Care and Use of Laboratory Animals. 
2.2. Catheter and cannula implantation 
For the reinstatement studies, rats were implanted with chronic 
indwelling jugular catheters under ketamine HCl (100 mg/kg, ip) and 
xylazine (2 mg/kg, ip) anesthesia and with bilateral 2.1-cm 23 gauge 
guide cannulae aimed at the VTA for intracranial injections as 
previously described (Blacktop et al., 2011 and Vranjkovic et al., 
2014). The tips of the guide cannulae were aimed 0.5 mm above the 
target injection site (the posterior VTA) using the following coordinates 
determined from Paxinos and Watson (2007): 12° angle away from 
midline; A/P − 5.6 mm from bregma; M/L ± 2.2 mm from midline; 
and D/V − 6.7 mm from the skull surface. Placements for cannula 
targeting the VTA for rats from each of the experiments are depicted 
in Fig. 1. 
 
Fig. 1. Intracranial injection sites. Panels represent atlas diagrams (coronal 
sections −5.6, −5.8 and −6.1 mm relative to Bregma; Paxinos and Watson, 2007) 
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depicting injection sites from rats included in experiments in which effects of VTA 
injections of 1 ng/side (closed circles), 10 ng/side (open circles), or 20 ng/side (open 
triangles) bicuculline on CRF- and shock-induced cocaine seeking were tested (left); 
rats included in experiments in which effects of VTA injections of 0.2 μg/side (closed 
circles) or 2 μg/side (open squares) 2-hydroxysaclofen on CRF- and shock-induced 
cocaine seeking were tested and rats with injections outside of the VTA used as 
anatomical controls (center; closed triangles); and rats included in the experiments 
testing for effects on food-reinforced lever pressing (right; closed circles). 
2.3. Drugs 
Cocaine HCl was provided by the National Institute on Drug 
Abuse through the Drug Supply Program. CRF was purchased from 
Sigma–Aldrich and was administered at a concentration of 500 ng/side 
(Blacktop et al., 2011) dissolved in artificial cerebral spinal fluid (aCSF; 
0.25 μl/side). The GABAA receptor antagonist (−)-bicuculline 
methiodide was purchased from Tocris Bioscience and was 
administered at doses of 1, 10 and 20 ng/side (0.002 and 0.02 and 
0.04 nmol/side) dissolved in aCSF (0.25 μl/side). The doses used were 
selected based on prior reports assessing VTA effects (Sandner et al., 
1996, Trojniar and Klejbor, 1999, Laviolette and van der Kooy, 2001, 
Grubb et al., 2002, Echo et al., 2002 and Lavezzi et al., 2015). The 
occurrence of seizures prevented testing for effects of higher doses. 
The GABAB receptor antagonist 2-hydroxysaclofen was also purchased 
from Tocris Bioscience and was administered at doses of 0.2 and 
2 μg/side (0.75 and 7.5 nmol/side) dissolved in aCSF (0.25 μl/side). 
The doses used were also selected based on prior reports assessing 
VTA effects (Xi and Stein, 1999, Echo et al., 2002, Ackerman et al., 
2003 and Miner et al., 2010). 
2.4. Cocaine self-administration/extinction 
After recovery from surgery, rats were trained to self-administer 
cocaine (1.0 mg/kg/inf, iv) by pressing a lever under a fixed ratio 1 
schedule during daily 2-h sessions, within which the active (i.e., front) 
lever was extended into the chamber and the corresponding stimulus 
light was illuminated. Pressing the lever resulted in an iv infusion of 
cocaine solution (200 μl over 5 s) followed by a 25-s time-out period 
during which the stimulus light was extinguished but the lever 
remained extended. Responding on a second, inactive (i.e., back) 
lever was recorded but had no programmed consequences. Response 
requirements were gradually increased until rats displayed stable 
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responding (within 10% of the mean over 3 consecutive sessions) 
under an FR4 schedule at which time they were allowed to self-
administer cocaine six hours daily for 14 consecutive days. We have 
previously found that robust reinstatement of cocaine seeking in 
response to either footshock or intra-VTA CRF is only observed when 
rats are tested after self-administration under these “long-access” 
conditions (Mantsch et al., 2008 and Blacktop et al., 2011). After the 
14-day self-administration test period rats underwent extinction during 
ten consecutive 2-h sessions within which the cocaine solution was 
replaced by saline. As was the case during self-administration, the 
drug lever stimulus light was illuminated during the extinction session 
except during the post-infusion “time-out” period. Once rats displayed 
less than 20 responses/session over two consecutive sessions under 
extinction conditions, reinstatement testing was initiated. 
2.5. Reinstatement testing 
After extinction, rats were tested for the effects of intra-VTA 
pretreatment with either bicuculline (GABAA antagonist) or 2-
hydroxysaclofen (GABAB antagonist) on reinstatement in response to 
electric footshock or bilateral intra-VTA CRF injections. Separate 
groups of rats were tested for the effects of 1 ng, 10 or 20 ng/side 
bicuculline or 0.2 or 2 μg/side 2-hydroxysaclofen. Each rat was tested 
for reinstatement in response to shock and intra-VTA CRF following 
intra-VTA vehicle and drug pretreatment (four reinstatement tests 
total). The two-hour reinstatement sessions were otherwise identical 
to the extinction sessions (i.e., the drug lever stimulus light was 
illuminated except during the post-infusion “time-out” period). 
Consecutive reinstatement sessions were always separated by 
additional extinction training and rats were required to display less 
than 20 cocaine lever responses during an intervening extinction 
session in order to be tested again for reinstatement. The sequence of 
reinstatement testing (shock and CRF) was counterbalanced across 
rats such that some rats were tested for effects on shock-induced 
reinstatement first, while others were tested for CRF-induced 
reinstatement first. All microinfusions were delivered in a volume of 
0.25 μl/side over a 1-min period with an additional 1-min period to 
allow for drug diffusion, ten minutes prior to the reinstatement 
session. In addition to testing for the effects of GABA receptor 
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antagonists on shock- and CRF-induced cocaine seeking, the effects of 
intra-VTA administration of bicuculline and 2-hydroxysaclofen in the 
absence of shock or CRF were assessed in separate groups of rats. 
2.6. Shock-induced reinstatement of cocaine seeking 
To determine the contribution of VTA GABAA and GABAB 
receptors to stress-induced cocaine seeking, rats were tested for the 
ability of electric footshock, delivered though the stainless steel grid 
floors of the self-administration chambers, to reinstate cocaine seeking 
following pretreatment with bilateral antagonist drug injections into 
the VTA ten minutes prior to shock. During the 15-min footshock 
period, the houselight was illuminated and the levers were retracted 
and stimulus lights extinguished. Shocks (0.5 mA, 0.5” duration) were 
delivered an average of every 40 s (range 10–70 s). Immediately 
following the shock period, the houselight was extinguished and the 
active and inactive levers were extended into the chamber and the 
active lever stimulus light was illuminated (conditions identical to both 
self-administration and extinction). We have reported that these 
parameters produce robust footshock-induced reinstatement under the 
self-administration conditions used (Mantsch et al., 2008). Each rat 
was tested twice for shock-induced reinstatement in counter-balanced 
sequence: once following intra-VTA drug delivery and once following 
intra-VTA vehicle administration. 
2.7. CRF-induced reinstatement of cocaine seeking 
Rats were also tested for reinstatement in response to bilateral 
intra-VTA injections of CRF. Ten minutes after VTA administration of 
bicuculline, 2-hydroxysaclofen or vehicle, rats received bilateral 
injections with CRF (500 ng/side delivered a volume of 0.25 μl/side 
over a 1-min period ten minutes prior to reinstatement testing). Each 
rat was tested twice for CRF-induced reinstatement in counter-
balanced sequence: once following intra-VTA drug delivery and once 
following intra-VTA vehicle administration. We have previously 
reported that this CRF concentration produces robust reinstatement 
under the self-administration conditions used (Blacktop et al., 2011). 
Moreover, CRF delivery via cannula placed into regions adjacent to the 
VTA failed to reinstate cocaine seeking (n = 5; extinction responses/2-
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
9 
 
h session: 11.2 ± 1.59; CRF-induced responses/2-h session: 
8.8 ± 1.39). 
2.8. Testing for effects on food-reinforced lever 
pressing 
In order to confirm that the effects of intra-VTA injections on 
reinstatement were not attributable to non-specific motor impairment, 
separate groups of rats were tested for effects on sucrose pellet-
reinforced lever pressing. These rats were maintained at 90% of their 
free-feeding body weights and trained to self-administer 45 mg 
sucrose-sweetened food pellets (BioServ) by pressing a response lever 
under a FR4 schedule of reinforcement during 30-min sessions. Once 
stable response patterns were observed (responding within 10% of the 
mean over 3 sessions), rats were tested for the effects of intra-VTA 
delivery of 2-hydroxysaclofen, as described above, on responding. 
2.9. Histological confirmation of injection sites 
The accuracy of cannula implantation was confirmed 
postmortem in each rat after cardiac perfusion with 60-ml NaCl 
followed by 60-ml 2.5% buffered neutral formalin under sodium 
barbital anesthesia (55 mg/kg). Brains were removed and stored in 
2.5% buffered formalin for at least one day. 200-μm sections were cut 
using a vibrotome, slide-mounted, and stained with cresyl violet for 
placement confirmation using a light microscope. Rats with injection 
sites outside of the VTA were excluded from the primary analysis and 
combined into a separate “missed placement” group for assessment of 
anatomical specificity of drug effects on shock-induced cocaine 
seeking. 
2.10. Statistical analyses 
The effects of each drug/dose combination on CRF and shock-
induced reinstatement were analyzed separately using 2-way repeated 
measure ANOVA with reinstatement (responding during the 
reinstatement session vs. the preceding extinction session) and intra-
VTA drug treatment (drug vs. vehicle) as factors. A similar analysis 
was used to assess effects on food-reinforced responding (2-way 
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repeated measures with reinforced lever pressing and drug treatment 
as factors). Analysis of drug effects alone consisted of comparison with 
the prior extinction session using paired t-tests. Statistical analyses 
were conducted using SPSS statistics software. For all analyses, 
statistical significance was defined as p < 0.05. 
3. Results 
3.1. Placements 
The sites of injections for rats tested for the effects of intra-VTA 
drug injections and for anatomical control rats are depicted in Fig. 1. 
3.2. SA and extinction 
Cocaine self-administration and extinction in rats used for each 
experiment are shown in Table 1 and were comparable across groups. 
Moreover, the numbers of sessions required for acquisition of cocaine 
self-administration, total cocaine intake across all self-administration 
sessions and the numbers of sessions needed to reach the extinction 
criteria did not differ across groups (data not shown). 
Table 1. Cocaine self-administration and extinction in each group of rats that 
underwent reinstatement testing. Data represent infusions/6-h session 
(±S.E.) on days 1 and 14 of self-administration and responses/2-h session 
(±S.E.) during the final extinction session prior to starting reinstatement 
testing in separate groups of rats tested for effects of intra-VTA bicuculline (1, 
10, or 20 ng/side) or 2-hydroxysaclofen (0.2 or 2 μg/side) on shock and CRF-
induced reinstatement. 
Intra-VTA pretreatment 
group 
Infusions/6-h session (±S.E.) 
 
Responses/2-h session 
(±S.E.) 
SA Day 1 SA Day 14 Last Ext Day 
Bicuculline (1 ng/side) 83.75 (±8.66) 92.75 (±14.07) 10.38 (±1.24) 
Bicuculline (10 ng/side) 79.00 (±7.57) 96.00 (±11.48) 14.57 (±3.46) 
Bicuculline (20 ng/side) 61.38 (±7.80) 83.00 (±17.21) 12.50 (±1.76) 
2-hydroxysaclofen 
(0.2 μg/side) 
70.80 (±3.81) 86.4 (±5.56) 10.20 (±1.56) 
2-hydroxysaclofen (2 μg/side) 72.22 (±3.27) 82.44 (±4.23) 6.22 (±1.54) 
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3.3. Intra-VTA injections of 2-hydroxysaclofen or 
bicuculline do not reinstate cocaine seeking 
Neither intra-VTA 2-hydroxysaclofen nor intra-VTA bicuculline 
injections induced cocaine-seeking behavior. Cocaine seeking following 
intra-VTA injections of bicuculline (10 or 20 ng/side; n = 4/dose) or 2-
hydroxysaclofen (0.2 or 2 μg/side; n = 5/dose) is shown in Fig. 2. 
Separate 2-way ANOVAs failed to show overall increases in responding 
(i.e., reinstatement) relative to extinction, effects of intra-VTA drug 
dose or reinstatement × dose interactions. 
 
Fig. 2. Intra-VTA injections of bicuculline or 2-hydroxysaclofen do not induce cocaine 
seeking. Data represent responding (lever presses/2-h session ±S.E.) recorded during 
reinstatement testing following intra-VTA injections of vehicle and bicuculline (BIC; 10 
or 20 ng/side;A) or 2-hydroxysaclofen (2-HS; 0.2 or 2 μg/side; B) and responding 
during the corresponding previous extinction (Ext) sessions. 
3.4. Effects of intra-VTA bicuculline injections on shock- 
and intra-VTA CRF-induced reinstatement 
Antagonism of GABAA receptors in the VTA failed to alter stress- 
or intra-VTA CRF-induced cocaine seeking. The effects of intra-VTA 
injections of three bicuculline concentrations (1 ng/side, 10 ng/side, 
and 20 ng/side) on shock-induced cocaine seeking were tested and are 
shown in Fig. 3. Consistent with other reports (e.g., Echo et al., 2002) 
we were unable to administer higher concentrations due to the 
emergence of seizures. Separate 2-way repeated measures 
(reinstatement × drug treatment) ANOVAs were conducted for each 
bicuculline dose. In all cases, shock-induced reinstatement was not 
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altered by intra-VTA bicuculline. At each bicuculline concentration, 
significant shock-induced reinstatement was observed (1 ng/side: 
F1,5 = 9.967, P < 0.05, n = 6; 10 ng/side: F1,4 = 42.631 P < 0.01, 
n = 5; 20 ng/side: F1,3 = 33.178 P = 0.01, n = 4). However significant 
effects of VTA bicuculline administration or significant 
bicuculline × reinstatement interactions were not found. 
 
Fig. 3. Effects of intra-VTA bicuculline injections on stress-induced reinstatement. 
Data represent responding (lever presses/2-h session ±S.E.) recorded during 
reinstatement testing following electric footshock (0.5 mA, 0.5″ shocks delivered an 
average of every 40 s over a 15-min period) in rats pretreated with intra-VTA 
injections of vehicle or 1 ng/side (A), 10 ng/side (B), or 20 ng/side (C) concentrations 
of the GABAA receptor antagonist, bicuculline (BIC), and responding during the 
previous extinction (Ext) session. Shock reinstated cocaine seeking regardless of 
whether rats were pretreated with vehicle or intra-VTA bicuculline (*P < 0.05 overall 
shock reinstatement effect vs. Ext but no effect of BIC or shock × BIC interaction). 
The effects of intra-VTA injections of the three bicuculline 
concentrations (1 ng/side, 10 ng/side, and 20 ng/side) on cocaine 
seeking in response to bilateral intra-VTA CRF injections (500 ng/side) 
are shown in Fig. 4. Separate 2-way repeated measures 
(reinstatement × drug treatment) ANOVAs were conducted for each 
bicuculline concentration. As was the case with shock, CRF-induced 
reinstatement was not altered by intra-VTA bicuculline. At each 
bicuculline concentration, significant CRF-induced reinstatement was 
observed (1 ng/side: F1,5 = 35.698, P = 0.001, n = 6; 10 ng/side: 
F1,4 = 15.896, P < 0.05, n = 5; 20 ng/side: F1,3 = 271.75, P < 0.001, 
n = 4). However significant effects of bicuculline administration or 
significant bicuculline × reinstatement interactions were not found. 
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Fig. 4. Effects of intra-VTA bicuculline injections on CRF-induced reinstatement. Data 
represent responding (lever presses/2-h session ±S.E.) recorded during reinstatement 
testing following bilateral intra-VTA administration of CRF (500 ng/side) in rats 
pretreated with intra-VTA injections of vehicle or 1 ng/side (A), 10 ng/side (B), or 
20 ng/side (C) concentrations of the GABAA receptor antagonist, bicuculline (BIC), and 
responding during the previous extinction (Ext) session. Intra-VTA CRF reinstated 
cocaine seeking regardless of whether rats were pretreated with vehicle or intra-VTA 
bicuculline (*P < 0.05 overall CRF reinstatement effect vs. Ext but no effect of BIC or 
CRF × BIC interaction). 
3.5. Effects of intra-VTA 2-hydroxysaclofen injections 
on shock- and intra-VTA CRF-induced reinstatement 
In contrast to bicuculline, bilateral injections of the GABAB 
receptor antagonist, 2-hydroxysaclofen, into the VTA prevented 
reinstatement in response to either shock delivery or intra-VTA CRF. 
The effects of intra-VTA injections of the two 2-hydroxysaclofen 
concentrations tested (0.2 μg/side and 2 μg/side) on shock-induced 
cocaine seeking are shown in Fig. 5. Separate 2-way repeated 
measures (reinstatement × drug treatment) ANOVAs were conducted 
for each 2-hydroxysaclofen concentration. In both cases significant 
overall shock-induced reinstatement (0.2 μg/side: F1,4 = 153.84, 
P < 0.001, n = 5; 2 μg/side: F1,7 = 14.322, P < 0.01, n = 8) and 
significant interactions between 2-hydroxysaclofen and shock-induced 
reinstatement (0.2 μg/side: F1,4 = 91.274, P = 0.001, n = 5; 
2 μg/side: F1,7 = 6.666, P < 0.05) were observed. Post-hoc testing 
showed that there was significant shock-induced reinstatement in rats 
pretreated with intra-VTA vehicle (P < 0.05) but not with either 2-
hydroxysaclofen dose. Moreover, reinstatement following intra-VTA 2-
hydroxysaclofen was significantly lower than following vehicle (0.2 
μg/side, P < 0.05; 2 μg/side, P = 0.05). 
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Fig. 5. Effects of intra-VTA 2-hydroxysaclofen injections on shock-induced 
reinstatement. Data represent responding (lever presses/2-h session ±S.E.) recorded 
during reinstatement testing following electric footshock (0.5 mA, 0.5″ shocks 
delivered an average of every 40 s over a 15-min period) in rats pretreated with intra-
VTA injections of vehicle or 0.2 μg/side (A) or 2 μg/side (B) of the GABAB receptor 
antagonist, 2-hydroxysaclofen (2-HS) and responding during the previous extinction 
(Ext) session. Shock reinstated cocaine seeking following vehicle (0 μg/side) 
pretreatment (*P < 0.05 vs. Ext) but not following injections of 0.2 or 2 μg/side 2-
hydroxysaclofen into the VTA. Moreover, lever pressing during the reinstatement 
session following shock delivery was significantly lower in rats that received intra-VTA 
injections of 0.2 or 2 μg/side 2-hydroxysaclofen relative to rats pretreated with vehicle 
(#P < 0.05 vs. 0 μg/side). By contrast, in rats with misplaced cannula that received 2-
hydroxysaclofen injections into brain regions adjacent to the VTA, 2-hydroxysaclofen 
(2 μg/side) failed to affects shock-induced reinstatement of cocaine seeking (C). 
To confirm anatomical localization of 2-hydroxysaclofen effects 
to the VTA, we also examined shock-reinstatement in a separate group 
of rats that received 2 μg/side 2-hydroxysaclofen injections via guide 
cannula implanted into regions adjacent to the VTA (n = 5; Fig. 5C). 
2-hydroxysaclofen had no effect on shock-induced reinstatement in 
these rats. A 2-way ANOVA showed a significant overall reinstatement 
effect (F1,4 = 109.606, P < 0.001) but no effect of 2-hydroxysaclofen 
and no reinstatement × 2-hydroxysaclofen interaction. 
The effects of intra-VTA injections of the two 2-hydroxysaclofen 
concentrations (0.2 μg/side and 2 μg/side) on cocaine seeking in 
response to intra-VTA CRF are shown in Fig. 6. As was the case with 
shock, significant overall intra-VTA CRF-induced reinstatement 
(500 ng/side: F1,4 = , P < 0.001, n = 5; 2 μg/side: F1,7 = , P < 0.01, 
n = 8) and significant interactions between 2-hydroxysaclofen and 
CRF-induced reinstatement (0.2 μg/side: F1,4 = P = 0.001, n = 5; 
2 μg/side: F1,7 = , P < 0.05) were observed. Post-hoc testing showed 
that there was significant CRF-induced reinstatement in rats pretreated 
with intra-VTA vehicle (P < 0.05) but not but not with either 2-
hydroxysaclofen dose. Additionally, reinstatement following intra-VTA 
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2-hydroxysaclofen was significantly lower than that observed following 
vehicle pretreatment (0.2 μg/side, P < 0.05; 2 μg/side, P = 0.05). 
 
Fig. 6. Effects of intra-VTA 2-hydroxysaclofen injections on CRF-induced 
reinstatement of extinguished cocaine seeking. Data represent responding (lever 
presses/2-h session ±S.E.) following bilateral intra-VTA administration of CRF 
(500 ng/side) in rats pretreated with intra-VTA injections of vehicle or the 0.2 μg/side 
(A) or 2 μg/side (B) concentration of the GABAB receptor antagonist, 2-
hydroxysaclofen (2-HS) and responding during the previous extinction (Ext) session. 
Intra-VTA CRF reinstated cocaine seeking following vehicle (0 μg/side) pretreatment 
(*P < 0.05 vs. Ext) but not following pretreatment with 0.2 or 2 μg/side 2-
hydroxysaclofen. Moreover, lever pressing during the reinstatement session following 
CRF administration was significantly lower in rats pretreated with 0.2 or 2 μg/side 2-
hydroxysaclofen relative to rats pretreated with vehicle (#P < 0.05 vs. 0 μg/side). 
3.6. Effects of intra-VTA bicuculline or 2-
hydroxysaclofen injections on food-reinforced 
responding 
To determine if non-specific behavioral suppression contributed 
to effects on cocaine seeking, separate groups of rats were tested for 
effects of intra-VTA drug (10 or 20 ng/side bicuculline or 0.2 or 
2 μg/side 2-hydroxysaclofen) or vehicle administration on lever-
pressing reinforced by sucrose-sweetened food pellets during a 30-min 
session (Table 2; n = 4–6/group). Two-way testing (baseline vs. test 
session preceded by VTA injection; within subjects) × drug (drug vs. 
vehicle; between subjects) ANOVAs failed to show effects of injection 
of any of the drugs into the VTA on food-reinforced responding (no 
significant effects of testing or drug or testing × drug interactions were 
observed. 
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Table 2. Effects of intra-VTA bicuculline or 2-HS injections on food-reinforced lever 
pressing. Data represent the numbers of sucrose-sweetened food pellet-reinforced 
lever presses during the 30-min session following bilateral intra-VTA injections of 
vehicle (n = 6), 10 ng/side bicuculline (n = 4), 20 ng/side bicuculline (n = 4), 0.2 μg 
2-hydroxysaclofen (n = 4), or 2 μg 2-hydroxysaclofen (n = 4) or during the preceding 
baseline session (Bas). Food-reinforced responding was not significantly altered by any 
of the VTA treatments. 
Intra-VTA 
treatment 
Vehicle 
 
Bicuculline 
(10 ng/side) 
 
Bicuculline 
(20 ng/side) 
 
2-HS 
(0.2 μg/side
) 
 
2-HS 
(2 μg/side) 
 
Bas Veh Bas Bic Bas Bic Bas 2-HS Bas 2-HS 
Responses/30 
min 
304.4 
(±17.5
) 
307.3 
(±17.9
) 
330.5 
(±28.7
) 
340.0 
(±17.9
) 
327.2 
(±28.7
) 
340.0 
(±27.6
) 
307.5 
(±15.1
) 
303.0 
(±13.7
) 
293.0 
(±25.4
4) 
286.0 
(±34.8
9) 
4. Discussion 
Our results demonstrate that intra-VTA injections of the GABAB 
receptor antagonist, 2-hydroxysaclofen, prevent reinstatement in 
response to either footshock stress or intra-VTA delivery of the 
stressor-responsive neuropeptide, CRF. These effects were observed at 
2-hydroxysaclofen doses that did not alter lever pressing reinforced by 
sucrose-sweetened food pellets and did not affect cocaine seeking in 
the absence of stress or CRF. By contrast, intra-VTA injections of the 
GABAA receptor antagonist, bicuculline across a range of doses, had no 
effects on shock- or CRF-induced reinstatement. Thus, the results 
suggest that 1) GABA release into the VTA and GABAB receptor 
activation are necessary for stress-induced cocaine seeking and 2) in 
the VTA, GABAB receptor activation is required for local CRF effects 
that underlie stress-induced cocaine seeking. 
The ventral tegmental area (VTA) is a key site at which inputs 
from a number of stress-responsive brain regions converge to regulate 
motivated behavior and reward and promote relapse to drug use in 
addicts. Understanding the mechanisms in the VTA through which 
stressors trigger cocaine use should facilitate the development of new 
and more effective treatment strategies. We and others have 
previously reported that CRF actions in the VTA are required for stress-
induced reinstatement following cocaine self-administration and that 
CRF delivery into the VTA is sufficient induce cocaine seeking (Wang 
et al., 2005, Wang et al., 2007, Blacktop et al., 2011 and Vranjkovic 
et al., 2014). These actions have been reported to involve both CRF-
R1 (Blacktop et al., 2011 and Chen et al., 2014) and CRF-R2 (Wang 
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et al., 2005 and Wang et al., 2007) receptors as well an interaction 
with the CRF binding protein (Wang et al., 2007). As is the case with 
many neuropeptides, the cellular effects of CRF in the VTA appear to 
involve a complex coordination of cellular function through a wide 
array of actions at presynaptic, postsynaptic and extrasynaptic sites. 
Much of the research examining CRF actions in the VTA has 
focused on its enhancement of excitatory neurotransmission (Wise and 
Morales, 2010). CRF directly excites dopamine and non-dopamine 
neurons in the VTA (Korotkova et al., 2006 and Wanat et al., 2008) 
and indirectly facilitates excitatory synaptic transmission in the VTA 
through post-synaptic trafficking of NMDA and AMPA receptors 
(Ungless et al., 2003 and Hahn et al., 2009) and promotion of 
glutamate release (Wang et al., 2005 and Hahn et al., 2009). Stress-
induced reinstatement following cocaine (Wang et al., 2005) or heroin 
SA (Wang et al., 2012) is associated with increased VTA glutamate 
levels, while intra-VTA delivery of kynurenic acid, an ionotropic 
glutamate receptor antagonist, prevents stress-induced reinstatement 
and corresponding increases in VTA dopamine levels (Wang et al., 
2005 and Wang et al., 2012). 
Less attention has been given to the role of VTA GABAergic 
neurotransmission in stress-induced drug seeking. Delivery of a 
combination of the GABAA receptor agonist, muscimol, and the GABAB 
receptor agonist, baclofen, into the VTA attenuates cocaine seeking in 
response to a number of stimuli, including a cocaine priming injection 
(McFarland and Kalivas, 2001), a cocaine-paired conditioned stimulus 
(Di Ciano and Everitt, 2004), and footshock stress (McFarland et al., 
2004). However, while these studies implicate the VTA in cocaine 
seeking, they provide limited mechanistic information regarding the 
precise role of GABA as they do not differentiate between the 
contributions of GABAA versus GABAB receptors and since, in contrast 
to agonist-based approaches, they do not differentiate between 
GABAergic mechanisms that are active during stress and those that 
are not. 
The actions of GABA in the VTA are complex. The VTA receives 
GABAergic inputs from a number of brain regions, including the 
nucleus accumbens (Yim and Mogenson, 1980 and Bocklisch et al., 
2013), periaqueductal gray (Omelchenko and Sesack, 2010), bed 
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nuclei of the stria terminalis (Kudo et al., 2012), lateral septum (Luo 
et al., 2011), laterodorsal tegmentum (Omelchenko and Sesack, 
2005), ventral pallidum (Mahler et al., 2014), and rostromedial 
tegmental area (Jhou et al., 2009, Matsui and Williams, 
2011 and Barrot et al., 2012). Moreover, VTA cell populations include 
GABAergic interneurons (Steffensen et al., 1998 and Cruz et al., 2004) 
and GABAergic projection neurons (Van Bockstaele and Pickel, 
1995 and Carr and Sesack, 2000) that may provide collateral GABA 
mediated regulation within the region (Omelchenko and Sesack, 
2009). Both GABAA and GABAB receptors are expressed on 
dopaminergic and non-dopaminergic cells in the VTA (Churchill et al., 
1992, Wirtshafter and Sheppard, 2001, Okada et al., 
2004 and Ciccarelli et al., 2012) where they can regulate excitability, 
signaling and neurotransmitter release (see Creed et al., 2014 for 
review). 
Stress-induced cocaine seeking is associated with altered 
GABAergic synaptic transmission in the VTA (Graziane et al., 2013). 
However, the mechanism through which GABAergic signaling 
contributes to cocaine seeking and its relationship to CRF has not been 
previously reported. It has been suggested that CRF-releasing 
terminals in the VTA, at least those that innervate dopamine neurons, 
are predominantly glutamatergic, based on synaptic morphology 
(Tagliaferro and Morales, 2008). However, as is the case with most 
neuropeptides, regional diffusion of CRF to sites that regulate 
GABAergic transmission is likely. CRF has been reported to promote 
inhibitory transmission in a number of other brain regions including the 
central amygdala (Nie et al., 2004, Bajo et al., 2008 and Roberto 
et al., 2010), dorsal raphe nucleus (Waselus et al., 2005 and Kirby 
et al., 2008) and bed nucleus of the stria terminalis (Kash and Winder, 
2006). In the VTA, CRF promotes GABA release via presynaptic 
receptor actions (Williams et al., 2014) as well as excitation of intrinsic 
GABA interneurons (Korotkova et al., 2006) and, through a 
postsynaptic CRFR1/GABAB receptor interaction, promotes GABA-
induced GIRK-mediated inhibitory postsynaptic currents (Beckstead 
et al., 2009). Thus, the blockade of stress-induced cocaine seeking by 
2-hydroxysaclofen could be attributable to 1) preventing the activation 
of GABAB receptors by GABA released in response to CRF and/or 2) 
disruption of a post-synaptic interactions between CRF and GABAB 
receptors. 
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The exact mechanism through which CRF interacts with GABAB 
receptors in the VTA to promote cocaine seeking is unclear but likely 
involves one of several possibilities. First, GABAB receptor activation 
could inhibit VTA GABAergic interneurons, thereby disinhibiting 
dopamine neurons that project to terminal field regions involved in 
stress-induced drug seeking such as the prelimbic cortex (Capriles 
et al., 2003 and McFarland et al., 2004) and nucleus accumbens 
(Shaham and Stewart, 1996 and Xi et al., 2004). It has been reported 
that, in contrast to VTA dopamine neurons, which are relatively 
insensitive to inhibition by the GABAB receptor agonist, baclofen, VTA 
GABA neurons are much more susceptible to baclofen inhibition (Bonci 
and Malenka, 1999 and Cruz et al., 2004; but see Margolis et al., 
2012), due in part to increased coupling of GABAB receptors to GIRK 
channels (Cruz et al., 2004). In fact, long-term potentiation at 
inhibitory synapses between descending D1 receptor-expressing 
nucleus accumbens GABAergic medium spiny neurons and VTA 
GABAergic interneurons, and the resulting downstream disinhibition of 
VTA dopamine neurons, have been shown to contribute to cocaine-
induced increases in dopamine neuronal excitability (Bocklisch et al., 
2013), while GABA-mediated interneuron suppression and the 
resulting of disinhibition of dopamine neurons have been proposed to 
underlie context-induced reinstatement of cocaine seeking (Luo et al., 
2011). Thus, to the extent that CRF selectively regulates GABAergic 
synapses on local interneurons via GABAB receptors, CRF inhibition of 
local interneuron populations and disinhibition of dopaminergic 
neurons could account for its effects on cocaine seeking. While 
intriguing, this possibility is inconsistent with the finding that VTA 
GABAB receptor antagonism does not decrease but rather increases the 
nucleus accumbens dopamine response to stress (Doherty and 
Gratton, 2007) and tends to be inconsistent with our own finding that 
VTA GABAA receptor antagonism using bicuculline, which should 
reproduce any effects of 2-hydroxysaclofen-mediated inhibition of VTA 
GABAergic interneurons, does not reinstate cocaine seeking. 
Alternatively, shock, via CRF, could promote GABA actions to 
decrease or alter the pattern of firing of VTA dopamine neurons, 
thereby promoting cocaine seeking. Indeed, Tan et al. (2012) have 
reported that footshock excites VTA GABA interneurons while also 
inhibiting of a large majority of dopamine neurons, consistent with 
reports that, while footshock activates a subpopulation of dopamine 
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neurons (Brischoux et al., 2009), most VTA neurons show a shock-
induced reduction in firing (Ungless et al., 2004). These findings are 
paralleled by reports that aversive stimuli often produce time-locked 
decreases in nucleus accumbens dopamine release, as measured using 
voltammetry (Badrinarayan et al., 2012, Roitman et al., 
2008 and Oleson et al., 2012). While the possibility that stressors can 
promote cocaine seeking via reductions in the activity of mesolimbic 
dopamine neurons is inconsistent with the assumption that stress-
induced drug seeking is mediated by elevated dopamine in the nucleus 
accumbens (Shaham and Stewart, 1996 and Xi et al., 2004; but see 
McFarland et al., 2004), we have recently reported that an aversive 
stimulus (intra-oral quinine delivery) that reduces dopamine levels in 
nucleus accumbens shell can reinstate cocaine seeking following self-
administration in rats (Twining et al., 2015). Moreover, both quinine-
induced cocaine seeking and quinine-induced reductions in nucleus 
accumbens dopamine levels are dependent on VTA CRF receptor 
activation (Twining et al., 2015). 
Another possibility is that the effects 2-hydroxysaclofen on 
cocaine seeking are attributable to antagonism of presynaptic GABAB 
receptors on the terminals of afferent projections into the VTA. It is 
well established that presynaptic GABAB receptors are important 
regulators of vesicular neurotransmitter release (see e.g., Takahashi 
et al., 1998, Sakaba and Neher, 2003 and Padgett and Slesinger, 
2010) and, in the VTA, GABAB receptors have been reported to 
regulate both GABA (Chen et al., 2015) and glutamate (Padgett et al., 
2012) release. Cocaine seeking and dopamine neurons in the VTA are 
negatively regulated by GABAergic efferents from several brain 
regions, including the ventral pallidum (Mahler et al., 2014) and the 
rostromedial tegmental area (Huff and LaLumiere, 2015). Thus, it is 
possible that GABAB antagonism disinhibits these afferents, thereby 
promoting GABA release and GABAA receptor-mediated inhibition of 
dopaminergic neurons and cocaine seeking. As would be the case with 
interneuron inhibition, our finding that intra-VTA bicuculline does not 
increase cocaine seeking would suggest that, to the extent that this 
mechanism applies, GABAergic inputs are not providing baseline tonic 
inhibition of dopamine neurons in the VTA. 
Alternatively, CRF-induced GABA release may exert 
heterosynaptic effects via GABAB receptors to regulate glutamatergic 
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transmission (Manzoni and Williams, 1999). Riegel and colleagues 
(Williams et al., 2014) have reported that CRF, via CRF-R2 receptor-
mediated effects on GABA release, can promote GABAB receptor 
activation on glutamatergic terminals, thereby attenuating glutamate 
release and offsetting CRF-R1 receptor mediated increases in 
excitatory regulation of VTA dopamine neurons. It has been 
hypothesized that, following cocaine self-administration, this CRF-R2 
receptor-driven inhibitory effect of GABA on excitatory transmission 
diminishes, resulting in a shift from inhibitory to excitatory regulation 
of dopamine neurons by CRF. While this represents an interesting 
mechanism through which CRF can regulate VTA dopamine neurons, 
according to this model, CRF effects on glutamatergic transmission in 
the VTA are no longer GABAB receptor-dependent after cocaine self-
administration. Moreover, it is not clear how GABAB receptor 
attenuation of excitatory neurotransmission would result in 
reinstatement. Notably, an important distinction between that study 
and ours is the use of yohimbine in combination with non-extinguished 
response-contingent cocaine-associated cues as reinstating stimuli 
which may involve unique neurocircuitry and/or activate VTA inputs in 
addition to those that are stimulated by stress alone. Nonetheless, this 
proposed mechanism does not seem to account for our current 
findings. 
When considering the possible contribution of VTA GABA to 
cocaine seeking it is also important to recognize that the regulation of 
neuronal firing patterns in the VTA by GABA is complex and does not 
necessarily result exclusively in inhibition of efferent pathways. 
Transient GABA-mediated inhibition may coordinate or synchronize 
regional network activity and/or prime neurons for excitation and burst 
firing. Indeed, it has been reported that GABAergic transmission in the 
VTA is critical for nicotine-induced excitation of dopamine neurons and 
associated behavioral responses (Tolu et al., 2013). 
Neither administration of bicuculline nor 2-hydroxysaclofen into 
the VTA alone was sufficient to induce cocaine seeking. Although 
reinstatement by intra-VTA bicuculline or 2-hydroxysaclofen has not, 
to our knowledge, been previously reported, these results were 
somewhat surprising to us, particularly in the case of bicuculline, which 
has been found to elevate nucleus accumbens dopamine levels 
(Ikemoto et al., 1997), increase locomotor activity (Grubb et al., 
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2002 and Lavezzi et al., 2015), and produce conditioned place 
preference (Laviolette and van der Kooy, 2001) when injected into the 
VTA and has been reported to be self-administered directly into the 
VTA in mice (David et al., 1997). As elevated dopamine in the nucleus 
accumbens (Cornish and Kalivas, 2000) and intra-accumbens delivery 
of dopamine receptor agonists (Bachtell et al., 2005 and Schmidt 
et al., 2006) have been reported to be sufficient for reinstatement of 
cocaine seeking, we predicted that intra-VTA GABA receptor 
antagonism would induce cocaine seeking, especially considering that 
GABA receptor agonist injections into the VTA suppress dopamine 
release (Yoshida et al., 1994), drug self-administration (Xi and Stein, 
1999, Brebner et al., 2000 and Backes and Hemby, 2008), and 
reinstatement (McFarland and Kalivas, 2001, Di Ciano and Everitt, 
2004 and McFarland et al., 2004). When considering the failure of 
GABA antagonists to induced cocaine seeking, the complexity of 
GABAergic regulation of the VTA and the understanding that distinct 
mechanisms contribute to reinforcement/reward vs. 
motivation/seeking should be taken into account. While it is possible 
that the antagonist doses used were insufficient to effectively target 
GABA receptors, we consider this unlikely, as the same 2-
hydroxysaclofen doses attenuated reinstatement and we were unable 
to test higher intra-VTA bicuculline doses due to the emergence of 
seizure activity, as has been previously described (Echo et al., 2002). 
To confirm that any GABA receptor antagonist effects on 
reinstatement were not attributable to non-specific behavioral 
disruption, separate groups of rats were tested for effects of intra-VTA 
antagonist injections on food-reinforced lever pressing. Neither 
bicuculline nor 2-hydroxysaclofen altered food-reinforced responding, 
suggesting that motor impairment likely did not contribute to 2-
hydroxysaclofen-induced reductions in shock- and CRF-induced 
reinstatement. Considering that optogenetic stimulation of VTA GABA 
neurons impairs natural reward consumption (van Zessen et al., 
2012), it is somewhat surprising that effects on food-reinforced 
responding were not observed. However, consistent with our findings, 
others have reported that GABAA and GABAB receptor antagonism in 
the VTA has minimal effects on feeding behavior (Echo et al., 2002, 
Ackerman et al., 2003 and Miner et al., 2010). When interpreting 
these findings, it is important to note that the rates of responding 
during the food-reinforced sessions (approximately 30 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
23 
 
responses/minute) were much higher than those during the 
reinstatement sessions. For this reason, less-pronounced disruption of 
motor performance that could have contributed to the observed effects 
on cocaine seeking or increases in responding attributable to 
enhancement of food reward may not have been detectable under 
these conditions. 
5. Conclusion 
To summarize, our results suggest that stress-induced 
reinstatement of extinguished cocaine seeking requires VTA GABAB 
receptor activation, likely via a CRF-regulated mechanism. While the 
precise process through which CRF interacts with GABAB receptors 
remains to be determined, these findings provide novel insight into 
mechanisms that contribute to stress-induced relapse and therefore 
may guide the development of new therapeutic approaches aimed at 
relapse prevention. 
Acknowledgments 
This work was supported by National Institute on Drug Abuse (NIDA) grant 
number DA15758 to John R. Mantsch. The authors acknowledge Chris Mueller 
for his technical assistance. 
References 
 
Ackerman et al., 2003. T.F. Ackerman, N. Lamonte, R.J. Bodnar. Lack of 
intersite GABA receptor subtype antagonist effects upon mu opioid 
receptor agonist-induced feeding elicited from either the ventral 
tegmental area or nucleus accumbens shell in rats. Physiol. Behav., 79 
(2003), pp. 191–198 
Badrinarayan et al., 2012. A. Badrinarayan, S.A. Wescott, C.M. Vander Weele, 
B.T. Saunders, B.E. Couturier, S. Maren, B.J. Aragona. Aversive stimuli 
differentially modulate real-time dopamine transmission dynamics 
within the nucleus accumbens core and shell. J. Neurosci., 32 (2012), 
pp. 15779–15790 
Bachtell et al., 2005. R.K. Bachtell, K. Whisler, D. Karanian, D.W. Self. Effects 
of intra-nucleus accumbens shell administration of dopamine agonists 
and antagonists on cocaine-taking and cocaine-seeking behaviors in 
the rat. Psychopharmacology, 183 (2005), pp. 41–53 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
24 
 
Backes and Hemby, 2008. E.N. Backes, S.E. Hemby. Contribution of ventral 
tegmental GABA receptors to cocaine self-administration in rats. 
Neurochem. Res., 33 (2008), pp. 459–467 
Bajo et al., 2008. M. Bajo, M.T. Cruz, G.R. Siggins, R. Messing, M. Roberto. 
Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA 
release in central amygdala. Proc. Natl. Acad. Sci. U. S. A., 105 
(2008), pp. 8410–8415 
Barrot et al., 2012. M. Barrot, S.R. Sesack, F. Georges, M. Pistis, S. Hong, 
T.C. Jhou. Braking dopamine systems: a new GABA master structure 
for mesolimbic and nigrostriatal functions. J. Neurosci., 32 (2012), pp. 
14094–14101 
Beckstead et al., 2009. M.J. Beckstead, S.C. Gantz, C.P. Ford, M.P. Stenzel-
Poore, P.E. Phillips, G.P. Mark, J.T. Williams. CRF enhancement of 
GIRK channel-mediated transmission in dopamine neurons. 
Neuropsychopharmacol, 34 (2009), pp. 1926–1935 
Blacktop et al., 2011. J.M. Blacktop, C. Seubert, D.A. Baker, N. Ferda, G. Lee, 
E.N. Graf, J.R. Mantsch. Augmented cocaine seeking in response to 
stress or CRF delivered into the ventral tegmental area following long-
access self-administration is mediated by CRF receptor type 1 but not 
CRF receptor type 2. J. Neurosci., 31 (2011), pp. 11396–11403 
Bocklisch et al., 2013. C. Bocklisch, V. Pascoli, J.C. Wong, D.R. House, C. 
Yvon, M. de Roo, K.R. Tan, C. Lüscher. Cocaine disinhibits dopamine 
neurons by potentiation of GABA transmission in the ventral tegmental 
area. Science, 341 (2013), pp. 1521–1525 
Bonci and Malenka, 1999. A. Bonci, R.C. Malenka. Properties and plasticity of 
excitatory synapses on dopaminergic and GABAergic cells in the 
ventral tegmental area. J. Neurosci., 19 (1999), pp. 3723–3730 
Brebner et al., 2000. K. Brebner, R. Phelan, D.C. Roberts. Intra-VTA baclofen 
attenuates cocaine self-administration on a progressive ratio schedule 
of reinforcement. Pharmacol. Biochem. Behav., 66 (2000), pp. 857–
862 
Brischoux et al., 2009. F. Brischoux, S. Chakraborty, D.I. Brierley, M.A. 
Ungless. Phasic excitation of dopamine neurons in ventral VTA by 
noxious stimuli. Proc. Natl. Acad. Sci. U. S. A., 106 (2009), pp. 4894–
4899 
Capriles et al., 2003. N. Capriles, D. Rodaros, R.E. Sorge, J. Stewart. A role 
for the prefrontal cortex in stress- and cocaine-induced reinstatement 
of cocaine seeking in rats. Psychopharmacology, 168 (2003), pp. 66–
74 
Carr and Sesack, 2000. D.B. Carr, S.R. Sesack. GABA-containing neurons in 
the rat ventral tegmental area project to the prefrontal cortex. 
Synapse, 38 (2000), pp. 114–123 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
25 
 
Chen et al., 2014. N.A. Chen, B. Jupp, Y. Sztainberg, M. Lebow, R.M. Brown, 
J.H. Kim, A. Chen, A.J. Lawrence. Knockdown of CRF1 receptors in the 
ventral tegmental area attenuates cue- and acute food deprivation 
stress-induced cocaine seeking in mice. J. Neurosci., 34 (2014), pp. 
11560–11570 
Chen et al., 2015. M. Chen, Y. Zhao, H. Yang, W. Luan, J. Song, D. Cui, Y. 
Dong, B. Lai, L. Ma, P. Zheng. Morphine disinhibits glutamatergic input 
to VTA dopamine neurons and promotes dopamine neuron excitation. 
Elife, 4 (2015) http://dx.doi.org/10.7554/eLife.09275 
Churchill et al., 1992. L. Churchill, R.P. Dilts, P.W. Kalivas. Autoradiographic 
localization of gamma-aminobutyric acidA receptors within the ventral 
tegmental area. Neurochem. Res., 17 (1992), pp. 101–106 
Ciccarelli et al., 2012. A. Ciccarelli, A. Calza, P. Panzanelli, A. Concas, M. 
Giustetto, M. Sassoè-Pognetto. Organization of GABAergic synaptic 
circuits in the rat ventral tegmental area. PLoS One, 7 (2012), p. 
e46250 
Cornish and Kalivas, 2000. J.L. Cornish, P.W. Kalivas. Glutamate transmission 
in the nucleus accumbens mediates relapse in cocaine addiction. 
J. Neurosci., 20 (2000), p. RC89 
Creed et al., 2014. M.C. Creed, N.R. Ntamati, K.R. Tan. VTA GABA neurons 
modulate specific learning behaviors through the control of dopamine 
and cholinergic systems. Front. Behav. Neurosci., 8 (2014), p. 8 
Cruz et al., 2004. H.G. Cruz, T. Ivanova, M.L. Lunn, M. Stoffel, P.A. Slesinger, 
C. Lüscher. Bi-directional effects of GABA(B) receptor agonists on the 
mesolimbic dopamine system. Nat. Neurosci., 7 (2004), pp. 153–159 
David et al., 1997. V. David, T.P. Durkin, P. Cazala. Self-administration of the 
GABAA antagonist bicuculline into the ventral tegmental area in mice: 
dependence on D2 dopaminergic mechanisms. Psychopharmacology, 
130 (1997), pp. 85–90 
Di Ciano and Everitt, 2004. P. Di Ciano, B.J. Everitt. Contribution of the 
ventral tegmental area to cocaine-seeking maintained by a drug-paired 
conditioned stimulus in rats. Eur. J. Neurosci., 19 (2004), pp. 1661–
1667 
Doherty and Gratton, 2007. M. Doherty, A. Gratton. Differential involvement 
of ventral tegmental GABA(A) and GABA(B) receptors in the regulation 
of the nucleus accumbens dopamine response to stress. Brain Res., 
1150 (2007), pp. 62–68 
Echo et al., 2002. J.A. Echo, N. Lamonte, T.F. Ackerman, R.J. Bodnar. 
Alterations in food intake elicited by GABA and opioid agonists and 
antagonists administered into the ventral tegmental area region of 
rats. Physiol. Behav., 76 (2002), pp. 107–116 
Erb and Stewart, 1999. S. Erb, J. Stewart. A role for the bed nucleus of the 
stria terminalis, but not the amygdala, in the effects of corticotropin-
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
26 
 
releasing factor on stress-induced reinstatement of cocaine seeking. 
J. Neurosci., 19 (1999), p. RC35 
Fox et al., 2005. H.C. Fox, M. Talih, R. Malison, G.M. Anderson, M.J. Kreek, R. 
Sinha. Frequency of recent cocaine and alcohol use affects drug 
craving and associated responses to stress and drug-related cues. 
Psychoneuroendocrinology, 30 (2005), pp. 880–891 
Graziane et al., 2013. N.M. Graziane, A.M. Polter, L.A. Briand, R.C. Pierce, 
J.A. Kauer. Kappa opioid receptors regulate stress-induced cocaine 
seeking and synaptic plasticity. Neuron, 77 (2013), pp. 942–954 
Grubb et al., 2002. M.C. Grubb, J.R. Welch, D.A. Finn, G.P. Mark. Cocaine 
self-administration alters the locomotor response to microinjection of 
bicuculline into the ventral tegmental area of rats. Brain Res., 952 
(2002), pp. 44–51 
Hahn et al., 2009. J. Hahn, F.W. Hopf, A. Bonci. Chronic cocaine enhances 
corticotropin-releasing factor-dependent potentiation of excitatory 
transmission in ventral tegmental area dopamine neurons. 
J. Neurosci., 29 (2009), pp. 6535–6544 
Huff and LaLumiere, 2015. M.L. Huff, R.T. LaLumiere. The rostromedial 
tegmental nucleus modulates behavioral inhibition following cocaine 
self-administration in rats. Neuropsychopharmacology, 40 (2015), pp. 
861–873 
Ikemoto et al., 1997. S. Ikemoto, R.R. Kohl, W.J. McBride. GABA(A) receptor 
blockade in the anterior ventral tegmental area increases extracellular 
levels of dopamine in the nucleus accumbens of rats. J. Neurochem., 
69 (1997), pp. 137–143 
Jhou et al., 2009. T.C. Jhou, H.L. Fields, M.G. Baxter, C.B. Saper, P.C. 
Holland. The rostromedial tegmental nucleus (RMTg), a GABAergic 
afferent to midbrain dopamine neurons, encodes aversive stimuli and 
inhibits motor responses. Neuron, 61 (2009), pp. 786–800 
Kash and Winder, 2006. T.L. Kash, D.G. Winder. Neuropeptide Y and 
corticotropin-releasing factor bi-directionally modulate inhibitory 
synaptic transmission in the bed nucleus of the stria terminalis. 
Neuropharmacology, 51 (2006), pp. 1013–1022 
Kirby et al., 2008. L.G. Kirby, E. Freeman-Daniels, J.C. Lemos, J.D. Nunan, C. 
Lamy, A. Akanwa, S.G. Beck. Corticotropin-releasing factor increases 
GABA synaptic activity and induces inward current in 5-
hydroxytryptamine dorsal raphe neurons. J. Neurosci., 28 (2008), pp. 
12927–12937 
Korotkova et al., 2006. T.M. Korotkova, R.E. Brown, O.A. Sergeeva, A.A. 
Ponomarenko, H.L. Haas. Effects of arousal- and feeding-related 
neuropeptides on dopaminergic and GABAergic neurons in the ventral 
tegmental area of the rat. Eur. J. Neurosci., 23 (2006), pp. 2677–2685 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
27 
 
Kudo et al., 2012. T. Kudo, M. Uchigashima, T. Miyazaki, K. Konno, M. 
Yamasaki, Y. Yanagawa, M. Minami, M. Watanabe. Three types of 
neurochemical projection from the bed nucleus of the stria terminalis 
to the ventral tegmental area in adult mice. J. Neurosci., 32 (2012), 
pp. 18035–18046 
Lavezzi et al., 2015. H.N. Lavezzi, K.P. Parsley, D.A. Zahm. Modulation of 
locomotor activation by the rostromedial tegmental nucleus. 
Neuropsychopharmacology, 40 (2015), pp. 676–687 
Laviolette and van der Kooy, 2001. S.R. Laviolette, D. van der Kooy. GABA(A) 
receptors in the ventral tegmental area control bidirectional reward 
signaling between dopaminergic and non-dopaminergic neural 
motivational systems. Eur. J. Neurosci., 13 (2001), pp. 1009–1015 
Luo et al., 2011. A.H. Luo, P. Tahsili-Fahadan, R.A. Wise, C.R. Lupica, G. 
Aston-Jones. Linking context with reward: a functional circuit from 
hippocampal CA3 to ventral tegmental area. Science, 333 (2011), pp. 
353–357 
Mahler et al., 2014. S.V. Mahler, E.M. Vazey, J.T. Beckley, C.R. Keistler, E.M. 
McGlinchey, J. Kaufling, S.P. Wilson, K. Deisseroth, J.J. Woodward, G. 
Aston-Jones. Designer receptors show role for ventral pallidum input to 
ventral tegmental area in cocaine seeking. Nat. Neurosci., 17 (2014), 
pp. 577–585 
Mantsch et al., 2008. J.R. Mantsch, D.A. Baker, D.M. Francis, E.S. Katz, M.A. 
Hoks, J.P. Serge. Stressor- and corticotropin releasing factor-induced 
reinstatement and active stress-related behavioral responses are 
augmented following long-access cocaine self-administration by rats. 
Psychopharmacology, 195 (2008), pp. 591–603 
Mantsch et al., 2015. J.R. Mantsch, D.A. Baker, D. Funk, A.D. Lê, Y. Shaham. 
Stress-induced reinstatement of drug seeking: 20 years of progress. 
Neuropsychopharmacology (2015) 
http://dx.doi.org/10.1038/npp.2015.142 
Manzoni and Williams, 1999. O.J. Manzoni, J.T. Williams. Presynaptic 
regulation of glutamate release in the ventral tegmental area during 
morphine withdrawal. J. Neurosci., 19 (1999), pp. 6629–6636 
Margolis et al., 2012. E.B. Margolis, B. Toy, P. Himmels, M. Morales, H.L. 
Fields. Identification of rat ventral tegmental area GABAergic neurons. 
PLoS One, 7 (2012), p. e42365 
Matsui and Williams, 2011. A. Matsui, J.T. Williams. Opioid-Sensitive GABA 
inputs from rostromedial tegmental nucleus synapse onto midbrain 
dopamine neurons. J. Neurosci., 31 (2011), pp. 17729–17735 
McFarland and Kalivas, 2001. K. McFarland, P.W. Kalivas. The circuitry 
mediating cocaine-induced reinstatement of drug-seeking behavior. 
J. Neurosci., 21 (2001), pp. 8655–8663 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
28 
 
McFarland et al., 2004. K. McFarland, S.B. Davidge, C.C. Lapish, P.W. Kalivas. 
Limbic and motor circuitry underlying footshock-induced reinstatement 
of cocaine-seeking behavior. J. Neurosci., 24 (2004), pp. 1551–1560 
Miner et al., 2010. P. Miner, Y. Borkuhova, L. Shimonova, A. Khaimov, R.J. 
Bodnar. GABA-A and GABA-B receptors mediate feeding elicited by the 
GABA-B agonist baclofen in the ventral tegmental area and nucleus 
accumbens shell in rats: reciprocal and regional interactions. Brain 
Res., 1355 (2010), pp. 86–96 
Nie et al., 2004. Z. Nie, P. Schweitzer, A.J. Roberts, S.G. Madamba, S.D. 
Moore, G.R. Siggins. Ethanol augments GABAergic transmission in the 
central amygdala via CRF1 receptors. Science, 303 (2004), pp. 1512–
2154 
Okada et al., 2004. H. Okada, N. Matsushita, K. Kobayashi, K. Kobayashi. 
Identification of GABAA receptor subunit variants in midbrain 
dopaminergic neurons. J. Neurochem., 89 (2004), pp. 7–14 
Oleson et al., 2012. E.B. Oleson, R.N. Gentry, V.C. Chioma, J.F. Cheer. 
Subsecond dopamine release in the nucleus accumbens predicts 
conditioned punishment and its successful avoidance. J. Neurosci., 32 
(2012), pp. 14804–14808 
Omelchenko and Sesack, 2005. N. Omelchenko, S.R. Sesack. Laterodorsal 
tegmental projections to identified cell populations in the rat ventral 
tegmental area. J. Comp. Neurol., 483 (2005), pp. 217–235 
Omelchenko and Sesack, 2009. N. Omelchenko, S.R. Sesack. Ultrastructural 
analysis of local collaterals of rat ventral tegmental area neurons: 
GABA phenotype and synapses onto dopamine and GABA cells. 
Synapse, 63 (2009), pp. 895–906 
Omelchenko and Sesack, 2010. N. Omelchenko, S.R. Sesack. Periaqueductal 
gray afferents synapse onto dopamine and GABA neurons in the rat 
ventral tegmental area. J. Neurosci. Res., 88 (2010), pp. 981–991 
Padgett and Slesinger, 2010. C.L. Padgett, P.A. Slesinger. GABAB receptor 
coupling to G-proteins and ion channels. Adv. Pharmacol., 58 (2010), 
pp. 123–147 
Padgett et al., 2012. C.L. Padgett, A.L. Lalive, K.R. Tan, M. Terunuma, M.B. 
Munoz, M.N. Pangalos, J. Martínez-Hernández, M. Watanabe, S.J. 
Moss, R. Luján, C. Lüscher, P.A. Slesinger. Methamphetamine-evoked 
depression of GABA(B) receptor signaling in GABA neurons of the VTA. 
Neuron, 73 (2012), pp. 978–989 
Paxinos and Watson, 2007. G. Paxinos, C. Watson. The Rat Brain in 
Stereotaxic Coordinates (sixth ed.), Academic Press (2007) 
Roberto et al., 2010. M. Roberto, M.T. Cruz, N.W. Gilpin, V. Sabino, P. 
Schweitzer, M. Bajo, P. Cottone, S.G. Madamba, D.G. Stouffer, E.P. 
Zorrilla, G.F. Koob, G.R. Siggins, L.H. Parsons. Corticotropin releasing 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
29 
 
factor-induced amygdala gamma-aminobutyric acid release plays a key 
role in alcohol dependence. Biol. Psychiatry, 67 (2010), pp. 831–839 
Roitman et al., 2008. M.F. Roitman, R.A. Wheeler, R.M. Wightman, R.M. 
Carelli. Real-time chemical responses in the nucleus accumbens 
differentiate rewarding and aversive stimuli. Nat. Neurosci., 11 (2008), 
pp. 1376–1377 
Sakaba and Neher, 2003. T. Sakaba, E. Neher. Direct modulation of synaptic 
vesicle priming by GABAB receptor activation at a glutamatergic 
synapse. Nature, 424 (2003), pp. 775–778 
Sandner et al., 1996. G. Sandner, C. Bielajew, G. Fouriezos. Bicuculline 
microinjections into the ventral tegmental area of the rat: alteration of 
self-stimulation thresholds and of cytochrome oxidase activity in the 
brain. Behav. Brain Res., 79 (1996), pp. 145–151 
Schmidt et al., 2006. H.D. Schmidt, S.M. Anderson, R.C. Pierce. Stimulation 
of D1-like or D2 dopamine receptors in the shell, but not the core, of 
the nucleus accumbens reinstates cocaine-seeking behaviour in the 
rat. Eur. J. Neurosci., 23 (2006), pp. 219–228 
Shaham and Stewart, 1996. Y. Shaham, J. Stewart. Effects of opioid and 
dopamine receptor antagonists on relapse induced by stress and re-
exposure to heroin in rats. Psychopharmacology, 125 (1996), pp. 385–
391 
Sinha et al., 1999. R. Sinha, D. Catapano, S. O'Malley. Stress-induced craving 
and stress response in cocaine dependent individuals. 
Psychopharmacology, 142 (1999), pp. 343–351 
Steffensen et al., 1998. S.C. Steffensen, A.L. Svingos, V.M. Pickel, S.J. 
Henriksen. Electrophysiological characterization of GABAergic neurons 
in the ventral tegmental area. J. Neurosci., 18 (1998), pp. 8003–8015 
Tagliaferro and Morales, 2008. P. Tagliaferro, M. Morales. Synapses between 
corticotropin-releasing factor-containing axon terminals and 
dopaminergic neurons in the ventral tegmental area are predominantly 
glutamatergic. J. Comp. Neurol., 506 (2008), pp. 616–626 
Takahashi et al., 1998. T. Takahashi, Y. Kajikawa, T. Tsujimoto. G-Protein-
coupled modulation of presynaptic calcium currents and transmitter 
release by a GABAB receptor. J. Neurosci., 18 (1998), pp. 3138–3146 
Tan et al., 2012. K.R. Tan, C. Yvon, M. Turiault, J.J. Mirzabekov, J. Doehner, 
G. Labouèbe, K. Deisseroth, K.M. Tye, C. Lüscher. GABA neurons of 
the VTA drive conditioned place aversion. Neuron, 73 (2012), pp. 
1173–1183 
Tolu et al., 2013. S. Tolu, R. Eddine, F. Marti, V. David, M. Graupner, S. Pons, 
M. Baudonnat, M. Husson, M. Besson, C. Reperant, J. Zemdegs, C. 
Pagès, Y.A. Hay, B. Lambolez, J. Caboche, B. Gutkin, A.M. Gardier, J.P. 
Changeux, P. Faure, U. Maskos. Co-activation of VTA DA and GABA 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
30 
 
neurons mediates nicotine reinforcement. Mol. Psychiatry, 18 (2013), 
pp. 382–393 
Trojniar and Klejbor, 1999. W. Trojniar, I. Klejbor. Facilitatory effect of 
unilateral lesion of the ventral tegmental area on locomotor response 
to stimulation of the contralateral ventral tegmental area: involvement 
of GABAergic transmission. Brain Res., 842 (1999), pp. 419–430 
Twining et al., 2015. R.C. Twining, D.S. Wheeler, A.L. Ebben, A.J. Jacobsen, 
M.A. Robble, J.R. Mantsch, R.A. Wheeler. Aversive stimuli drive drug 
seeking in a state of low dopamine tone. Biol. Psychiatry, 77 (2015), 
pp. 895–902 
Ungless et al., 2003. M.A. Ungless, V. Singh, T.L. Crowder, R. Yaka, D. Ron, 
A. Bonci. Corticotropin-releasing factor requires CRF binding protein to 
potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. 
Neuron, 39 (2003), pp. 401–407 
Ungless et al., 2004. M.A. Ungless, P.J. Magill, J.P. Bolam. Uniform inhibition 
of dopamine neurons in the ventral tegmental area by aversive stimuli. 
Science, 303 (2004), pp. 2040–2042 
Van Bockstaele and Pickel, 1995. E.J. Van Bockstaele, V.M. Pickel. GABA-
containing neurons in the ventral tegmental area project to the 
nucleus accumbens in rat brain. Brain Res., 682 (1995), pp. 215–221 
van Zessen et al., 2012. R. van Zessen, J.L. Phillips, E.A. Budygin, G.D. 
Stuber. Activation of VTA GABA neurons disrupts reward consumption. 
Neuron, 73 (2012), pp. 1184–1194 
Vranjkovic et al., 2014. O. Vranjkovic, P.J. Gasser, C.H. Gerndt, D.A. Baker, 
J.R. Mantsch. Stress-induced cocaine seeking requires a beta-2 
adrenergic receptor-regulated pathway from the ventral bed nucleus of 
the stria terminalis that regulates CRF actions in the ventral tegmental 
area. J. Neurosci., 34 (2014), pp. 12504–12514 
Wanat et al., 2008. M.J. Wanat, F.W. Hopf, G.D. Stuber, P.E. Phillips, A. 
Bonci. Corticotropin-releasing factor increases mouse ventral 
tegmental area dopamine neuron firing through a protein kinase C-
dependent enhancement of Ih. J. Physiol., 586 (2008), pp. 2157–2170 
Wanat et al., 2013. M.J. Wanat, A. Bonci, P.E. Phillips. CRF acts in the 
midbrain to attenuate accumbens dopamine release to rewards but not 
their predictors. Nat. Neurosci., 16 (2013), pp. 383–385 
Wang et al., 2005. B. Wang, Y. Shaham, D. Zitzman, S. Azari, R.A. Wise, Z.B. 
You. Cocaine experience establishes control of midbrain glutamate and 
dopamine by corticotropin-releasing factor: a role in stress-induced 
relapse to drug seeking. J. Neurosci., 25 (2005), pp. 5389–5396 
Wang et al., 2007. B. Wang, Z.B. You, K.C. Rice, R.A. Wise. Stress-induced 
relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-
binding protein in the ventral tegmental area of the rat. 
Psychopharmacology, 193 (2007), pp. 283–294 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
31 
 
Wang et al., 2012. B. Wang, Z.B. You, R.A. Wise. Heroin self-administration 
experience establishes control of ventral tegmental glutamate release 
by stress and environmental stimuli. Neuropsychopharmacology, 37 
(2012), pp. 2863–2869 
Waselus et al., 2005. M. Waselus, R.J. Valentino, E.J. Van Bockstaele. 
Ultrastructural evidence for a role of gamma-aminobutyric acid in 
mediating the effects of corticotropin-releasing factor on the rat dorsal 
raphe serotonin system. J. Comp. Neurol., 482 (2005), pp. 155–165 
Wirtshafter and Sheppard, 2001. D. Wirtshafter, A.C. Sheppard. Localization 
of GABA(B) receptors in midbrain monoamine containing neurons in 
the rat. Brain Res. Bull., 56 (2001), pp. 1–5 
Williams et al., 2014. C.L. Williams, W.C. Buchta, A.C. Riegel. CRF-R2 and the 
heterosynaptic regulation of VTA glutamate during reinstatement of 
cocaine seeking. J. Neurosci., 34 (2014), pp. 10402–10414 
Wise and Morales, 2010. R.A. Wise, M. Morales. A ventral tegmental CRF-
glutamate-dopamine interaction in addiction. Brain Res., 1314 (2010), 
pp. 38–43 
Xi and Stein, 1999. Z.X. Xi, E.A. Stein. Baclofen inhibits heroin self-
administration behavior and mesolimbic dopamine release. 
J. Pharmacol. Exp. Ther., 290 (1999), pp. 1369–1374 
Xi et al., 2004. Z.X. Xi, J. Gilbert, A.C. Campos, N. Kline, C.R. Ashby Jr., J.J. 
Hagan, C.A. Heidbreder, E.L. Gardner. Blockade of mesolimbic 
dopamine D3 receptors inhibits stress-induced reinstatement of 
cocaine-seeking in rats. Psychopharmacology, 176 (2004), pp. 57–65 
Xia et al., 2011. Y. Xia, J.R. Driscoll, L. Wilbrecht, E.B. Margolis, H.L. Fields, 
G.O. Hjelmstad. Nucleus accumbens medium spiny neurons target 
non-dopaminergic neurons in the ventral tegmental area. J. Neurosci., 
31 (2011), pp. 7811–7816 
Yim and Mogenson, 1980. C.Y. Yim, G.J. Mogenson. Effect of picrotoxin and 
nipecotic acid on inhibitory response of dopaminergic neurons in the 
ventral tegmental area to stimulation of the nucleus accumbens. Brain 
Res., 199 (1980), pp. 466–473 
Yoshida et al., 1994. M. Yoshida, H. Yokoo, T. Tanaka, H. Emoto, M. Tanaka. 
Opposite changes in the mesolimbic dopamine metabolism in the 
nerve terminal and cell body sites induced by locally infused baclofen 
in the rat. Brain Res., 636 (1994), pp. 111–114 
 
Corresponding author. Department of Biomedical Sciences, Marquette 
University, USA. 
Current address: Department of Integrative Physiology and Neuroscience, 
Washington State University Vancouver, USA. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropharmacology, Vol 102 (March 2016): pg. 197-206. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
32 
 
 
 
 
